racemetirosine has been researched along with Recrudescence in 4 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the effects of catecholamine depletion with alpha-methylparatyrosine (AMPT) on mood indices in patients with bipolar disorder who were in long-term remission with lithium therapy." | 9.09 | Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. ( Anand, A; Berman, RM; Cappiello, A; Charney, DS; Darnell, A; Miller, HL; Oren, DA; Woods, SW, 1999) |
| "This study investigated the effects of catecholamine depletion with alpha-methylparatyrosine (AMPT) on mood indices in patients with bipolar disorder who were in long-term remission with lithium therapy." | 5.09 | Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. ( Anand, A; Berman, RM; Cappiello, A; Charney, DS; Darnell, A; Miller, HL; Oren, DA; Woods, SW, 1999) |
| "Biochemical studies confirmed its recurrence." | 1.29 | An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside. ( Acheson, LS; Anton, AH; Lina, AA; Sherman, BW, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anton, AH | 1 |
| Sherman, BW | 1 |
| Lina, AA | 1 |
| Acheson, LS | 1 |
| Berman, RM | 2 |
| Narasimhan, M | 1 |
| Miller, HL | 2 |
| Anand, A | 2 |
| Cappiello, A | 2 |
| Oren, DA | 2 |
| Heninger, GR | 1 |
| Charney, DS | 2 |
| Darnell, A | 1 |
| Woods, SW | 1 |
| Abi-Dargham, A | 1 |
| Rodenhiser, J | 1 |
| Printz, D | 1 |
| Zea-Ponce, Y | 1 |
| Gil, R | 1 |
| Kegeles, LS | 1 |
| Weiss, R | 1 |
| Cooper, TB | 1 |
| Mann, JJ | 1 |
| Van Heertum, RL | 1 |
| Gorman, JM | 1 |
| Laruelle, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Imaging Cannabinoid CB1 Receptors in Schizophrenia[NCT01063335] | 1 participants (Actual) | Observational | 2010-02-01 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for racemetirosine and Recrudescence
| Article | Year |
|---|---|
Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker?
Topics: Adult; alpha-Methyltyrosine; Catecholamines; Cross-Over Studies; Depressive Disorder; Double-Blind M | 1999 |
Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder.
Topics: Adult; alpha-Methyltyrosine; Antimanic Agents; Bipolar Disorder; Catecholamines; Double-Blind Method | 1999 |
2 other studies available for racemetirosine and Recrudescence
| Article | Year |
|---|---|
An atrial pheochromocytoma-induced hypertensive crisis resistant to nitroprusside.
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Catecholamines; Drug Resistance; Echocardiography; Fe | 1993 |
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
Topics: Adult; alpha-Methyltyrosine; Antipsychotic Agents; Chronic Disease; Corpus Striatum; Dopamine; Femal | 2000 |